Accelerate Diagnostics Inc reports results for the quarter ended in December - Earnings Summary

Accelerate Diagnostics

08/03/2022 23:27

* Accelerate Diagnostics Inc  AXDX.OQ  reported a quarterly
adjusted loss of 35 cents​​ per share for the quarter ended in
December. The mean expectation of five analysts for the quarter
was for a loss of 25 cents per share.
    * Revenue rose 7.5% to $3.34 million from a year ago; 
analysts
expected $3.70 million. 
    * Accelerate Diagnostics Inc's reported EPS for the quarter
was a
loss of 35 cents​.
    * The mean earnings estimate of analysts had fallen by
about 7.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Accelerate Diagnostics Inc shares had fallen by 53.1% this
quarter.
    * The company reported a quarterly loss of $22.8 million.
    * Wall Street's median 12-month price target for Accelerate
Diagnostics Inc is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated March 8 at 11:26 p.m.  ​All
figures in US dollars unless otherwise stated